Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 May 2022
Robert Frater
The research efforts in the Department of Cardiothoracic Surgery in the Faculty of Health Sciences, UFS, have come a long way since the establishment of a homograft bank, animal research, and laboratory-based research on cardioplegia by Prof Hannes Meyer in the 1980s

Several world-class scientists and academics in the field of cardiovascular research will converge at the University of the Free State (UFS) on Thursday (5 May 2022) for a one-day hybrid conference to explore and celebrate the massive strides made in this critical field at the UFS Robert W M Frater Cardiovascular Research Centre.

The research efforts in the Department of Cardiothoracic Surgery in the Faculty of Health Sciences, UFS, have come a long way since the establishment of a homograft bank, animal research, and laboratory-based research on cardioplegia by Prof Hannes Meyer in the 1980s. Renewed interest in 2004 under the leadership of Prof Francis E Smit culminated in the establishment of the Robert W M Frater Cardiovascular Research Centre (the Frater Centre) in 2015. This was made possible through donor funding, especially by Dr Robert W M Frater MD PhD (honoris causa, UFS), a South Africa-born New York-based cardiothoracic surgeon, researcher and innovator as infrastructure and project support by the UFS.

The vision of the Frater Centre is to be a leading cardiovascular research institution in South Africa and sub-Saharan Africa. It provides an interdisciplinary training and research platform for scientists and clinicians from different backgrounds to develop as researchers and collaborators in cardiovascular and thoracic surgery and related domains. Activities are focused on the development of African solutions for African problems.

Three main divisions
The Frater Celebration day will highlight the achievements made thus far in a hybrid format in four sessions, which can be attended on a virtual platform or in person. The centre’s local and international collaborators will participate in the programme, and Dr Ronnie van der Merwe, the Group CEO of Mediclinic International, is the guest of honour.

The Frater Centre consists of three main divisions, all of which will form part of the focus of the conference programme in various forms during the day:

1) The Clinical Research Division addresses cardiovascular disease on a broad front, ranging from population and prevalence studies, healthcare solutions and clinical outcomes studies in a specific South African and African context.

2) The Research, Development and Commercialisation division is divided into Tissue Engineering and Cell Biology, Tissue Banking and Large Animal studies, and bioengineering to develop African solutions and technology within these domains.

3) The Simulation Programme provides an integrated interdisciplinary platform for the education and training of individuals and teams in cardiovascular, thoracic, anaesthetic, perfusion technology and related nursing fields in a state-of-the-art simulation unit. The research centre is developing a unique and leading programme and systems in this field. This endeavour is also developing IT models for training, evaluation and research.

The Frater Centre and 4IR
The Centre is firmly established in the fourth industrial revolution. It is new technology-driven, creating new IT platforms and boasts extensive interdisciplinary projects at the biomedical sector's local, national, and international levels.

It is essential to note that the extensive and successful collaboration within the Frater Centre not only exists on institutional level but also nationally and internationally. These collaborators assist, mentor, direct and contribute to the research activities.

Click: Link to the event
Event programme



News Archive

Louzanne Coetzee heading for Paralympic Games in Rio
2016-08-02

Description: Louzanne Coetzee  Tags: Louzanne Coetzee

Louzanne Coetzee (left) from the University of the
Free State and her guide Khothatso Mokone, a former Kovsie,
will compete in the Paralympic Games in Rio de Janeiro,
Brazil, from 7 to 18 September 2016.
Photo: Rufus Botha

Her perseverance and faith. Faith in herself and her coaches, as well as her Christian faith. Rufus Botha says this is what makes the Paralympic athlete Louzanne Coetzee special. According to her coach, the 23-year-old star from the University of the Free State (UFS) is easy to work with. “Her work ethic is incredible. As coach, I actually have to stop her,” he jokes. “She does not like to rest.”

On 19 July 2016, Coetzee was included in South Africa’s Paralympic team for the Olympics in Rio de Janeiro, Brazil. She and her guide Khothatso Mokone, also a former Kovsie, were included in the team that will participate in Rio from 7 to 18 September 2016.

Sights still set on 2020 Olympics

In Brazil, Coetzee will compete in the T11 category in the 1 500 m. The blind athlete is also outstanding in the 800 m and 5 000 m, of which she is the world record holder, but these items do not feature at the Olympics.

Botha says Coetzee has her sights still set on the 2020 Paralympic Games in Tokyo, Japan. “Anything she achieves in Rio will actually be a bonus.” He says it was an achievement on its own to be included in the SA team among established athletes such as Arnu Fourie and Ilse (Hayes) Carstens.

CUADS super proud of record-breaker

“Anything she achieves in Rio
will actually be a bonus.”


“Louzanne is an absolute star and an example to so many Kovsie students,” says Martie Miranda, Head of the Centre for Universal Access and Disability Support (CUADS) at the UFS. “We are super proud of her.”

On 17 July 2016, Coetzee set a new Africa record (5:00:25) in the 1 500 m in Berlin. She will leave for Rio on 30 August 2016, with her heat taking place on 15 September 2016 and the finals on 17 September 2016.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept